Clorox (NYSE:CLX) Hits New 1-Year Low – Here’s What Happened

Shares of The Clorox Company (NYSE:CLX) reached a new 52-week low during trading on Monday . The company traded as low as $103.43 and last traded at $103.4930, with a volume of 1689687 shares trading hands. The stock had previously closed at $104.27.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of analyst reports. BNP Paribas Exane reduced their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. TD Cowen cut their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Rothschild & Co Redburn decreased their price objective on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Morgan Stanley lowered their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Finally, UBS Group set a $119.00 target price on Clorox and gave the stock a “neutral” rating in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $125.69.

Clorox Stock Performance

The firm has a market capitalization of $12.21 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 0.92 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock’s 50-day moving average is $116.67 and its 200-day moving average is $122.95.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the business earned $1.86 earnings per share. The company’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 5.0%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently added to or reduced their stakes in CLX. Simplicity Wealth LLC grew its stake in Clorox by 157.3% in the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after purchasing an additional 11,198 shares during the period. Raymond James Financial Inc. raised its stake in shares of Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after purchasing an additional 36,352 shares during the period. Nuance Investments LLC raised its stake in shares of Clorox by 182.5% during the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock worth $101,832,000 after purchasing an additional 547,839 shares during the period. Vise Technologies Inc. purchased a new position in shares of Clorox in the 2nd quarter worth about $328,000. Finally, Nordea Investment Management AB grew its position in Clorox by 16.3% during the second quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock valued at $57,827,000 after buying an additional 68,026 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.